PTI-80

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePTI-80
Drug Alias NameExebryl-1PTI-80
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionBeta amyloid A4 protein inhibitorsMicrotubule-associated protein tau inhibitors
TargetsMicrotubule-associated protein tauBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesProteotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProteotechTianjin Tasly Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A